Clinical & Translational Immunology

Papers
(The TQCC of Clinical & Translational Immunology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
100
86
The spectrum of B cells in the pathogenesis, diagnosis and therapeutic applications of immunoglobulin G4‐related disease42
Circulating cytokine and chemokine patterns associated with cytomegalovirus reactivation after stem cell transplantation36
SARS‐CoV‐2‐associated T‐cell infiltration in the central nervous system34
Characteristics of PD‐1+CD4+ T cells in peripheral blood and synovium of rheumatoid arthritis patients30
Biomarkers to predict and diagnose pulmonary complications in children post haematopoietic stem cell transplant28
Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID‐19 lung disease27
25
25
23
The contribution of the alternative pathway in complement activation on cell surfaces depends on the strength of classical pathway initiation22
Mass cytometry analysis reveals altered immune profiles in patients with coronary artery disease22
Effects of extremely preterm birth on cytokine and chemokine responses induced by T‐cell activation during infancy22
Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine22
Endogenous bystander killing mechanisms enhance the activity of novel FAP‐specific CAR‐T cells against glioblastoma21
Retrospective analysis of the efficacy of adjuvant cytokine‐induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery19
19
Targeting BMI‐1 to deplete antibody‐secreting cells in autoimmunity19
Validation and performance of a multiplex serology assay to quantify antibody responses following SARS‐CoV‐2 infection or vaccination19
Siglec‐1, an easy and contributory inflammation marker in rheumatology18
Naturally acquired adaptive immunity to Streptococcus pneumoniae is impaired in rheumatoid arthritis patients17
Inhibitory effect of hydroxychloroquine on glucocorticoid‐induced osteoporosis in lupus therapy17
Increased mast cell activation in eosinophilic chronic obstructive pulmonary disease17
16
16
High KRT17 expression in tumour budding indicates immunologically ‘hot’ tumour budding and predicts good survival in patients with colorectal cancer15
Robust immunity to influenza vaccination in haematopoietic stem cell transplant recipients following reconstitution of humoral and adaptive immunity15
Identification of distinct immune signatures in inclusion body myositis by peripheral blood immunophenotyping using machine learning models14
Identification of polo‐like kinase 1 as a therapeutic target in murine lupus14
Prediction of intravenous immunoglobulin retreatment in children with Kawasaki disease using models combining lymphocyte subset and cytokine profile in an East Asian cohort13
13
CD39 expression defines exhausted CD4+ T cells associated with poor survival and immune evasion in human gastric cancer13
Increased amphiregulin expression by CD4+ T cells from individuals with asymptomatic Leishmania donovani infection13
A preclinical study of allogeneic CD19 chimeric antigen receptor double‐negative T cells as an off‐the‐shelf immunotherapy drug against B‐cell malignancies13
Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosis13
Data standards for single‐cell RNA‐sequencing of paediatric cancer13
12
Hypoxia‐inducible factor‐1α regulates the interleukin‐6 production by B cells in rheumatoid arthritis12
Epstein–Barr virus infection, B‐cell dysfunction and other risk factors converge in gut‐associated lymphoid tissue to drive the immunopathogenesis of multiple sclerosis: a hypothesis12
12
Immunoregulatory effects of testosterone supplementation combined with exercise training in men with Inclusion Body Myositis: a double‐blind, placebo‐controlled, cross‐over trial12
Pulmonary complications post allogeneic haematopoietic stem cell transplant in children11
Genome‐wide off‐target analyses of CRISPR/Cas9‐mediated T‐cell receptor engineering in primary human T cells11
A unique cytotoxic CD4+ T cell‐signature defines critical COVID‐1911
Targeting SARS‐CoV‐2 infection through CAR‐T‐like bispecific T cell engagers incorporating ACE211
Importance of crosstalk between the microbiota and the neuroimmune system for tissue homeostasis10
Adoptive T‐cell therapy targeting Epstein–Barr virus as a treatment for multiple sclerosis10
10
Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis10
Effect of washed versus unwashed red blood cells on transfusion‐related immune responses in preterm newborns10
Inflammasome activation: from molecular mechanisms to autoinflammation10
10
Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2 and COVID‐19 vaccination9
Multi‐omics integration reveals a nonlinear signature that precedes progression of lung fibrosis9
Spatial proteomic profiling of tumor and stromal compartments in non‐small‐cell lung cancer identifies signatures associated with overall survival9
Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients9
Serological responses and clinical outcomes following a three‐dose primary COVID‐19 vaccine schedule in kidney transplant recipients and people on dialysis9
Graft CD8 T‐cell‐based risk system predicts survival in antithymocyte globulin‐based myeloablative haploidentical peripheral blood stem cell transplantation8
Blood transcriptomics identifies immune signatures indicative of infectious complications in childhood cancer patients with febrile neutropenia8
Homologous peptides derived from influenza A, B and C viruses induce variable CD8+ T cell responses with cross‐reactive potential8
Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients8
Understanding the tumor microenvironment in head and neck squamous cell carcinoma8
Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma8
Sex‐bias in CD8+ T‐cell stemness and exhaustion in cancer8
0.043026208877563